Biological Alemtuzumab Clinical Trials Updates During the Last 45 Dayshttp://clinicaltrialsfeeds.org/clinical-trials/results/term=Biological+alemtuzumabClinical trials database search returned results for the query Biological alemtuzumab AND ( "04/14/2012" : MAX ) [LAST-RELEASE-DATE].Tue, 29 May 2012 17:42:29 GMTImprime PGG, Alemtuzumab, and Rituximab in Treating Patients With High Risk Chronic Lymphocytic Leukemiahttp://clinicaltrialsfeeds.org/clinical-trials/show/NCT01269385http://clinicaltrialsfeeds.org/clinical-trials/show/NCT01269385Status: Recruiting, Condition Summary: B-cell Chronic Lymphocytic Leukemia; Refractory Chronic Lymphocytic Leukemia; Stage 0 Chronic Lymphocytic Leukemia; Stage I Chronic Lymphocytic Leukemia; Stage II Chronic Lymphocytic LeukemiaWed, 18 Apr 2012 04:00:00 GMTAlemtuzumab and Combination Chemotherapy in Treating Patients With Untreated Acute Lymphoblastic Leukemiahttp://clinicaltrialsfeeds.org/clinical-trials/show/NCT00061945http://clinicaltrialsfeeds.org/clinical-trials/show/NCT00061945Status: Active, not recruiting, Condition Summary: LeukemiaMon, 14 May 2012 04:00:00 GMTImmunotherapy in Peripheral T Cell Lymphoma - the Role of Alemtuzumab in Addition to Dose Dense CHOPhttp://clinicaltrialsfeeds.org/clinical-trials/show/NCT00725231http://clinicaltrialsfeeds.org/clinical-trials/show/NCT00725231Status: Recruiting, Condition Summary: Peripheral T Cell Lymphoma, Unspecified; Angioimmunoblastic Lymphadenopathy; Extranodal NK/T-cell LymphomaFri, 04 May 2012 04:00:00 GMTReduced Intensity Hematopoietic Cell Transplantation for Patients With Resistant Langerhans Cell Histiocytosishttp://clinicaltrialsfeeds.org/clinical-trials/show/NCT00618540http://clinicaltrialsfeeds.org/clinical-trials/show/NCT00618540Status: Recruiting, Condition Summary: Histiocytosis, Langerhans-cellTue, 22 May 2012 04:00:00 GMTSCH 727965 in Patients With Mantle Cell Lymphoma or B-Cell Chronic Lymphocytic Leukemia (Study P04715AM2)(TERMINATED)http://clinicaltrialsfeeds.org/clinical-trials/show/NCT00871546http://clinicaltrialsfeeds.org/clinical-trials/show/NCT00871546Status: Terminated, Condition Summary: Lymphoma, Mantle-Cell; Leukemia, Lymphocytic, Chronic, B-CellWed, 09 May 2012 04:00:00 GMTMatched Unrelated or Non-Genotype Identical Related Donor Transplantation For Chronic Granulomatous Diseasehttp://clinicaltrialsfeeds.org/clinical-trials/show/NCT00578643http://clinicaltrialsfeeds.org/clinical-trials/show/NCT00578643Status: Recruiting, Condition Summary: Chronic Granulomatous DiseaseFri, 18 May 2012 04:00:00 GMTAllogeneic Bone Marrow Transplantation From HLA Identical Related Donors for Patients With Hemoglobinopathieshttp://clinicaltrialsfeeds.org/clinical-trials/show/NCT00578344http://clinicaltrialsfeeds.org/clinical-trials/show/NCT00578344Status: Recruiting, Condition Summary: Sickle Cell Disease; Hemoglobin SCWed, 09 May 2012 04:00:00 GMTFludarabine and PK-Directed Busulfan With or Without ATG Followed By Donor Peripheral Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Diseaseshttp://clinicaltrialsfeeds.org/clinical-trials/show/NCT00448357http://clinicaltrialsfeeds.org/clinical-trials/show/NCT00448357Status: Active, not recruiting, Condition Summary: Chronic Myeloproliferative Disorders; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic SyndromesTue, 22 May 2012 04:00:00 GMT